Angel® Catheter Early Feasibility Clinical Study

Stopped early · Not applicable

Conditions studied: Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism

In brief

The primary objective of this clinical trial is to obtain initial insights into the safety of the Angel® Catheter in critically ill subjects with high risk of venous thromboembolism (VTE) disease AND who are not receiving pharmacological thromboprophylaxis.

Key facts

Study ID

NCT01847196

Run by

BiO2 Medical

People needed

6

Starts

2013-11-01

Expected to finish

2014-06-01

Last updated by the study team

2015-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Mississippi Medical Center — Jackson, Mississippi, United States
• Oregon Health and Science University — Portland, Oregon, United States
• University of Texas Southwestern Medical Center - Dallas — Dallas, Texas, United States
• University of Texas Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.